Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Takahashi, Tamaki ^a   Muro, Shigeo ^a   Tanabe, Naoya ^a   Terada, Kunihiko ^a   Kiyokawa, Hirofumi ^a   Sato, Susumu ^a   Hoshino, Yuma ^a   Ogawa, Emiko ^b   Uno, Kazuko ^c   Naruishi, Koji ^d   Takashiba, Shogo ^e   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Louis Pasteur Center for Medical Research   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR; FLUTICASONE PROPIONATE PLUS SALMETEROL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LONG ACTING DRUG; PLATELET DERIVED GROWTH FACTOR; TIOTROPIUM BROMIDE; UNINDEXED DRUG;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING HABIT; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; COHORT STUDIES; CYTOKINES; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

PORPHYROMONAS GINGIVALIS;

EID: 84863816025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040570     Document Type: Article

References (42)

1. Global strategy for diagnosis, management, and prevention of COPD updated 2010. Available from http://www.goldcopd.com.
2. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, et al. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138.
3. Stoller JK, (2002) Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 346: 988-994.
4. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA, (2000) Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55: 114-120.
5. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, et al. (2002) Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759-764.
6. Terada K, Muro S, Sato S, Ohara T, Haruna A, et al. (2008) Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 63: 951-955.
7. Terada K, Muro S, Ohara T, Kudo M, Ogawa E, et al. (2010) Abnormal swallowing reflex and COPD exacerbations. Chest 137: 326-332.
8. Kullberg E, Sjogren P, Forsell M, Hoogstraate J, Herbst B, et al. (2010) Dental hygiene education for nursing staff in a nursing home for older people. J Adv Nurs 66: 1273-1279.
9. Sjogren P, Kullberg E, Hoogstraate J, Johansson O, Herbst B, et al. (2010) Evaluation of dental hygiene education for nursing home staff. J Adv Nurs 66: 345-349.
10. Drinka P, (2010) Preventing aspiration in the nursing home: the role of biofilm and data from the ICU. J Am Med Dir Assoc 11: 70-77.
11. Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, et al. (1994) Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65: 260-267.
12. Brook I, Frazier EH, (2003) Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis. Chest 124: 832-833.
13. Leuckfeld I, Obregon-Whittle MV, Lund MB, Geiran O, Bjortuft O, et al. (2008) Severe chronic obstructive pulmonary disease: association with marginal bone loss in periodontitis. Respir Med 102: 488-494.
14. Deo V, Bhongade ML, Ansari S, Chavan RS, (2009) Periodontitis as a potential risk factor for chronic obstructive pulmonary disease: a retrospective study. Indian J Dent Res 20: 466-470.
15. Yamazaki K, Honda T, Domon H, Okui T, Kajita K, et al. (2007) Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol 149: 445-452.
16. Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, et al. (2003) Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol 23: 1250-1254.
17. Bohnstedt S, Cullinan MP, Ford PJ, Palmer JE, Leishman SJ, et al. (2010) High antibody levels to P. gingivalis in cardiovascular disease. J Dent Res 89: 938-942.
18. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, et al. (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106: 196-204.
19. Murayama Y, Nagai A, Okamura K, Kurihara H, Nomura Y, et al. (1988) Serum immunoglobulin G antibody to periodontal bacteria. Adv Dent Res 2: 339-345.
20. Sugi N, Naruishi K, Kudo C, Hisaeda-Kako A, Kono T, et al. (2011) Prognosis of periodontitis recurrence after intensive periodontal treatment using examination of serum IgG antibody titer against periodontal bacteria. J Clin Lab Anal 25: 25-32.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
22. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, et al. (2000) Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67: 495-501.
23. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, et al. (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58: 100-105.
24. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, et al. (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543-1554.
25. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
26. Bascones-Martinez A, Matesanz-Perez P, Escribano-Bermejo M, Gonzalez-Moles MA, Bascones-Ilundain J, et al. (2011) Periodontal disease and diabetes-Review of the Literature. Med Oral Patol Oral Cir Bucal 16: e722-729.
27. Mealey BL, Oates TW, (2006) Diabetes mellitus and periodontal diseases. J Periodontol 77: 1289-1303.
28. Pussinen PJ, Alfthan G, Tuomilehto J, Asikainen S, Jousilahti P, (2004) High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction. Eur J Cardiovasc Prev Rehabil 11: 408-411.
29. Renvert S, (2003) Destructive periodontal disease in relation to diabetes mellitus, cardiovascular diseases, osteoporosis and respiratory diseases. Oral Health Prev Dent 1 Suppl 1: 341-357; discussison 358-349.
30. Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, et al. (2004) Antibodies to periodontal pathogens and stroke risk. Stroke 35: 2020-2023.
31. Sims TJ, Schifferle RE, Ali RW, Skaug N, Page RC, (2001) Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. Oral Microbiol Immunol 16: 193-201.
32. Lamster IB, Kaluszhner-Shapira I, Herrera-Abreu M, Sinha R, Grbic JT, (1998) Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis. J Clin Periodontol 25: 510-516.
33. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, et al. (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157: 1498-1505.
34. Surendar J, Mohan V, Rao MM, Babu S, Aravindhan V, (2011) Increased Levels of Both Th1 and Th2 Cytokines in Subjects with Metabolic Syndrome (CURES-103). Diabetes Technology & Therapeutics 13: 477-482.
35. Baskar P, Silberstein DS, Pincus SH, (1990) Inhibition of IgG-triggered human eosinophil function by IL-4. J Immunol 144: 2321-2326.
36. Paul WE, Ohara J, (1987) B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol 5: 429-459.
37. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, et al. (1988) Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333: 571-573.
38. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, et al. (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173: 1114-1121.
39. Becker Y, (2006) Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33: 235-252.
40. Zhang M, Li Q, Zhang XY, Ding X, Zhu D, et al. (2010) Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis 29: 1487-1493.
41. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184: 662-671.
42. Rosell A, Monso E, Soler N, Torres F, Angrill J, et al. (2005) Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165: 891-897.